vhla town hall on belzutifan (welireg)
Published 3 years ago • 1.1K plays • Length 1:05:17Download video MP4
Download video MP3
Similar videos
-
59:03
vhla town hall on welireg
-
7:45
practice update: belzutifan fda approval for vhl-associated cancers
-
33:29
welireg (belzutifan) q&a session with dr. othon iliopoulos
-
0:10
belzutifan - welireg - in a nutshell.
-
3:46
practice update: updated results of belzutifan for advanced rcc
-
2:09
promising real-world outcomes of belzutifan in vhl-associated tumors
-
40:40
belzutifan for vhl-associated tumors: a molecules to medicine success story—elaine t. lam, md, facp
-
29:08
fda approval of belzutifan | eric jonasch, md
-
6:09
belzutifan for vhl disease-associated renal cell carcinoma
-
2:03
avery latta-raines story on welireg drug
-
1:48
dr. jonasch on next steps with mk-6482 in von hippel-lindau disease–associated rcc
-
1:10
curing cancer through vhl
-
14:07
unique characteristics of vhl pancreatic tumors by diagnostic criteria | reut halperin, md, phd
-
41:39
systemic therapy for von hippel-lindau associated tumors | ramaprasad srinivasan, md, phd
-
30:25
role of renal ablative therapy and minimally invasive surgery in vhl treatment | benjamin chung, md
-
3:55
welireg (belzutifan) - drug rx information
-
1:55
belzutifan real-world vs clinical trial data: comparing efficacy and safety in vhl-associated tumors
-
22:30
vhl breakthrough: an expert discussion
-
13:17
belzutifan for von hippel-lindau syndrome